Intellectual Property India Publishes Patent Application for 'Substituted 6-Imidazopyridazine Il-17a Modulators And Uses Thereof' Filed by Dice Alpha, Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517097348 A) filed by Dice Alpha, Inc., Indianapolis, on Oct. 9, for 'substituted 6-imidazopyridazine il-17a modulators and uses thereof.'

Inventor(s) include Belabed, Hassane; Brandt, Gary Edward Lee; Fatheree, Paul R.; Freidberg, Michael D; and Reilly, Maureen K.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The disclosure herein provides substituted 6-imidazopyridazine compounds and pharmaceutical compositions thereof, for the modulation of IL-17A. These compounds are useful in the treatment of inflammatory conditions such as psoriasis, psoriatic arthritis, or ankylosing spondylitis."

The patent application was internationally filed on Apr. 08, 2024, under International application No.PCT/US2024/023545.

Disclaimer: Curated by HT Syndication.